Pre-Test Tackling Myths about Long-Acting Injectables in Schizophrenia: LAIs are Only for Nonadherence (Module 1) Pre-Test In a 12-week trial of aripiprazole lauroxil in patients experiencing acute exacerbation of schizophrenia, treatment with 882 mg of aripiprazole lauroxil monthly was _____ more effective than placebo. 1x 2x 3x 4x Unsure In the RISE study, once monthly risperidone and once every 2 months risperidone demonstrated reductions of ___ and ___ in relapse risk compared to placebo. 20%, 32.5% 40%, 52.5% 60%, 72.5% 80%, 62.5% Unsure Please now rate your ability to use currently available therapies to manage schizophrenia. Excellent Very Good Good Fair Poor
